To a certain extent, these results suggest that the inflammatory conditions in psoriasis mice contributed to microbiota transplantation from 6-month-old K14-VEGF-A-transgenic mice into 2-month-old K14-VEGF-A-transgenic mice, thereby resulting in metabolic disorders. Here, KRT14 is linked to metabolic disease.